Fate Therapeutics FATE
NASDAQ FATE
$2.30 -0.07 (-2.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Invested Capital (2012 - 2019)

Updated

Fate Therapeutics' Invested Capital was $281.97 million in Q3 2019, up 49.4% from $188.79 million a year earlier and up 98.0% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Invested Capital (2012 - 2019) Analysis & Trends

For FY2018, Invested Capital at Fate Therapeutics came in at $175.35 million, up 90.6% from FY2017.

  • Invested Capital has now increased for four consecutive years, with a five-year compound annual growth rate of 27.2% (FY2013 to FY2018).
  • In earlier years, Invested Capital was $92 million in FY2017 (+9.7%), $83.84 million in FY2016 (+31.1%), $63.97 million in FY2015 (+33.4%) and $47.95 million in FY2014 (-8.8%).
  • The Q3 2019 figure marks the highest quarterly Invested Capital in data going back to Q4 2012.
  • Compared with a year earlier, Invested Capital has increased for six straight quarters, with growth averaging 73.0% over the last eight quarters.
  • The best year-over-year quarter for Invested Capital over five years was Q3 2018 (growth of 211.9%); the worst was Q2 2016 (a decline of 35.5%).
  • Per Business Quant data, FATE's Invested Capital in the three quarters before Q3 2019 was $142.44 million (Q2 2019), $160.74 million (Q1 2019) and $175.35 million (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Fate Therapeutics 276.57 Mn 276.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 281.97 Mn
Jun 30, 2019 142.44 Mn
Mar 31, 2019 160.74 Mn
Dec 31, 2018 175.35 Mn
Sep 30, 2018 188.79 Mn
Jun 30, 2018 66.67 Mn
Mar 31, 2018 79.82 Mn
Dec 31, 2017 92.00 Mn
Sep 30, 2017 60.54 Mn
Jun 30, 2017 61.89 Mn
Mar 31, 2017 80.23 Mn
Dec 31, 2016 83.84 Mn
Sep 30, 2016 46.12 Mn
Jun 30, 2016 45.64 Mn
Mar 31, 2016 54.96 Mn
Dec 31, 2015 63.97 Mn
Sep 30, 2015 64.12 Mn
Jun 30, 2015 70.77 Mn
Mar 31, 2015 40.92 Mn
Dec 31, 2014 47.95 Mn
API Access

Fate Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=FATE&period=max&api_key=YOUR_API_KEY